Christopher B. Brooke

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

Nir Drayman, Jennifer K. DeMarco, Krysten A. Jones et al. · Science · 2021 · 255 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness

Ruian Ke, Pamela P. Martinez, Rebecca L. Smith et al. · Nature Microbiology · 2022 · 221 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +12

Most Influenza A Virions Fail To Express at Least One Essential Viral Protein

Christopher B. Brooke, William L. Ince, Jens Wrammert et al. · Journal of Virology · 2013 · 194 citations · Full text

Life Sciences, Microbiology, Molecular Biology +14

Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection

Rebecca L. Smith, Laura Gibson, Pamela P. Martinez et al. · The Journal of Infectious Diseases · 2021 · 163 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

Saliva-Based Molecular Testing for SARS-CoV-2 that Bypasses RNA Extraction

Diana Rose E. Rañoa, Robin L. Holland, Fadi G. Alnaji et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 137 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Biology +17